95
Views
41
CrossRef citations to date
0
Altmetric
Review

Caveolin-1: a multifaceted driver of breast cancer progression and its application in clinical treatment

, , , , , & show all
Pages 1539-1552 | Published online: 27 Feb 2019

References

  • HarbeckNGnantMBreast cancerLancet2017389100741134115027865536
  • AnwarSLWahyonoAAryandonoTHaryonoSJCaveolin-1 in breast cancer: single molecule regulation of multiple key signaling pathwaysAsian Pac J Cancer Prev201516166803681226514450
  • WardEMDesantisCELinCCCancer statistics: breast cancer in situCA Cancer J Clin201565648149526431342
  • DesantisCEMaJGoding SauerANewmanLAJemalABreast Cancer statistics, 2017, racial disparity in mortality by stateCA Cancer J Clin201767643944828972651
  • WachterDLWachterPWFaschingPACharacterization of molecular subtypes of Paget disease of the breast using immunohistochemistry and in situ hybridizationArch Pathol Lab Med2019143220621130124327
  • VranicSMarchiòCCastellanoIImmunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breastHum Pathol20154691350135926208846
  • RenMLiuFZhuYAbsence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcomeVirchows Arch2014465329129824980157
  • WangCYeQCaoYDownregulation of regulator of G protein signaling 2 expression in breast invasive carcinoma of NO special type: clinicopathological associations and prognostic relevanceOncol Lett201815121322029391880
  • SelviVNoriJMeattiniIRole of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinomaBiomed Res Int2018201817
  • ObeidatFNAhramMAl-KhaderAExpression of androgen receptor in invasive ductal breast carcinomas: a clinicopathological study from JordanAnn Saudi Med201838532633530284987
  • SørlieTPerouCMTibshiraniRGene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProc Natl Acad Sci U S A20019819108691087411553815
  • JhanJRAndrechekERTriple-negative breast cancer and the potential for targeted therapyPharmacogenomics201718171595160929095114
  • AysolaKDesaiAWelchCTriple negative breast cancer – an overviewHereditary Genet20132013Suppl 2
  • ChengCLThikeAATanSYChuaPJBayBHTanPHExpression of FGFR1 is an independent prognostic factor in triple-negative breast cancerBreast Cancer Res Treat201515119911125868865
  • YueYAstvatsaturyanKCuiXZhangXFraassBBoseSStratification of prognosis of triple-negative breast cancer patients using combinatorial biomarkersPLoS One2016113e014966126930401
  • OmidvariSHamediSHMohammadianpanahMVery late relapse in breast cancer survivors: a report of 6 casesIran J Cancer Prev20136211311725250120
  • CollignonJLousbergLSchroederHJerusalemGTriple-negative breast cancer: treatment challenges and solutionsBreast Cancer201689310727284266
  • EbisawaMIwanoHNishikawaMSignificance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumoursVet J2015206219119626364240
  • ShinodaHLegareMEMasonGLSignificance of ERα, HER2, and CaV1 expression and molecular subtype classification to canine mammary gland tumorJ Vet Diagn Invest201426339040324760135
  • EttlinJClementiEAminiPMalbonAMarkkanenEAnalysis of gene expression signatures in cancer-associated stroma from canine mammary tumours reveals molecular homology to human breast carcinomasInt J Mol Sci2017185E110128531107
  • Drews-ElgerKIornsEDiasAInfiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcomeBreast Cancer Res Treat20141481415925270120
  • ChengJPXNicholsBJCaveolae: one function or many?Trends Cell Biol201626317718926653791
  • Martinez-OutschoornUESotgiaFLisantiMPCaveolae and signalling in cancerNat Rev Cancer201515422523725801618
  • EcharriAdel PozoMACaveolaeCurr Biol2012224R114R11622361143
  • ChamberlainLHDetergents as tools for the purification and classification of lipid raftsFEBS Lett20045591–31514986659
  • TottaPGionfraFBusoneroCAcconciaFModulation of 17β-estradiol signaling on cellular proliferation by caveolin-2J Cell Physiol201623161219122526480297
  • KovtunOTilluVAAriottiNPartonRGCollinsBMCavin family proteins and the assembly of caveolaeJ Cell Sci201512871269127825829513
  • WangSWangNZhengYZhangJZhangFWangZCaveolin-1: an oxidative stress-related target for cancer preventionOxid Med Cell Longev20172017120
  • ParatMORigginsGJCaveolin-1, caveolae, and glioblastomaNeurooncology2012146679688
  • ThompsonMAPrakashYSPabelickCMThe role of caveolae in the pathophysiology of lung diseasesExpert Rev Respir Med20148111112224308657
  • DuhonDBigelowRLHColemanDTThe polyphenol epigal-locatechin-3-gallate affects lipid rafts to block activation of the c-met receptor in prostate cancer cellsMol Carcinog201049873974920623641
  • PikeLJGrowth factor receptors, lipid rafts and caveolae: an evolving storyBiochim Biophys Acta20051746326027315951036
  • GleissmanHSegerströmLHambergMOmega-3 fatty acid supplementation delays the progression of neuroblastoma in vivoInt J Cancer201112871703171120499314
  • GuptaRToufailyCAnnabiBCaveolin and cavin family members: dual roles in cancerBiochimie2014107Pt B18820225241255
  • QuestAFLobos-GonzálezLNuñezSThe caveolin-1 connection to cell death and survivalCurr Mol Med201313226628123228128
  • PeterMEHadjiAMurmannAEThe role of CD95 and CD95 ligand in cancerCell Death Differ201522454955925656654
  • ChenDCheGValue of caveolin-1 in cancer progression and prognosis: emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (review)Oncol Lett2014841409142125202343
  • Al-AnsariMMAboussekhraACaffeine mediates sustained inactivation of breast cancer-associated myofibroblasts via up-regulation of tumor suppressor genesPLoS One201493e9090724595168
  • PataniNMartinLAReis-FilhoJSDowsettMThe role of caveolin-1 in human breast cancerBreast Cancer Res Treat2012131111521901387
  • MercierILisantiMPCaveolin-1 and breast cancer: a new clinical perspectiveAdv Exp Med Biol2012729839422411315
  • FuPChenFPanQThe different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinomaOnco Targets Ther20171081983528243118
  • MollinedoFde La Iglesia-VicenteJGajateCIn vitro and in vivo selective antitumor activity of edelfosine against mantle cell lymphoma and chronic lymphocytic leukemia involving lipid raftsClin Cancer Res20101672046205420233887
  • GajateCMollinedoFEdelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid raftsBlood2007109271171917003375
  • NaHKSurhYJThe antitumor ether lipid edelfosine (ET-18-O-CH3) induces apoptosis in H-ras transformed human breast epithelial cells: by blocking ERK1/2 and p38 mitogen-activated protein kinases as potential targetsAsia Pac J Clin Nutr200817Suppl 120420718296338
  • ChantômeAPotier-CartereauMClarysseLPivotal role of the lipid raft SK3-Orai1 complex in human cancer cell migration and bone metastasesCancer Res201373154852486123774210
  • DuCChenLZhangHCaveolin-1 limits the contribution of BKCa channel to MCF-7 breast cancer cell proliferation and invasionInt J Mol Sci20141511207062072225397596
  • LiangYNLiuYWangLCombined caveolin-1 and epidermal growth factor receptor expression as a prognostic marker for breast cancerOncol Lett20181569271928229805656
  • NahtaRYuDHungMCHortobagyiGNEstevaFJMechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancerNat Clin Pract Oncol20063526928016683005
  • AlawinOAAhmedRAIbrahimBABriskiKPSylvesterPWAntiproliferative effects of γ-tocotrienol are associated with lipid raft disruption in HER2-positive human breast cancer cellsJ Nutr Biochem20162726627726507543
  • WangRLiZGuoHCaveolin 1 knockdown inhibits the proliferation, migration and invasion of human breast cancer BT474 cellsMol Med Rep2014951723172824604116
  • KangJParkJHLeeHJCaveolin-1 modulates docetaxel-induced cell death in breast cancer cell subtypes through different mechanismsCancer Res Treat201648271572626511813
  • XuFWangXWuNBisphenol A induces proliferative effects on both breast cancer cells and vascular endothelial cells through a shared GPER-dependent pathway in hypoxiaEnviron Pollut2017231Pt 21609162028964603
  • MontiDSotgiaFWhitaker-MenezesDPilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-acetylcysteine in breast cancerSemin Oncol201744322623229248134
  • MartinsDBeçaFFSousaBBaltazarFParedesJSchmittFLoss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinomaCell Cycle201312162684269023907124
  • AlbanitoLLappanoRMadeoAEffects of atrazine on estrogen receptor α- and G protein-coupled receptor 30-mediated signaling and proliferation in cancer cells and cancer-associated fibroblastsEnviron Health Perspect2015123549349925616260
  • LiuJJinXZhaoNYeXYingCBisphenol A promotes X-linked inhibitor of apoptosis protein-dependent angiogenesis via G protein-coupled estrogen receptor pathwayJ Appl Toxicol201535111309131725663485
  • Castillo SanchezRGomezRPerez SalazarEBisphenol A induces migration through a GPER-, FAK-, Src-, and ERK2-dependent pathway in MDA-MB-231 breast cancer cellsChem Res Toxicol201629328529526914403
  • SemenzaGLThe hypoxic tumor microenvironment: a driving force for breast cancer progressionBiochim Biophys Acta186320163382391
  • ShiXYXiongLXXiaoLDownregulation of caveolin-1 upregulates the expression of growth factors and regulators in co-culture of fibroblasts with cancer cellsMol Med Rep201613174475226647977
  • LiTKonNJiangLTumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescenceCell201214961269128322682249
  • ZhangLRenXAltEChemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosisNature201046472911058106120348907
  • PfefferCMSinghATKApoptosis: a target for anticancer therapyInt J Mol Sci2018192E44829393886
  • YuCLiWBLiuJBLuJWFengJFAutophagy: novel applications of nonsteroidal anti-inflammatory drugs for primary cancerCancer Med20187247148429282893
  • DaskalakiIGkikasITavernarakisNHypoxia and selective autophagy in cancer development and therapyFront Cell Dev Biol2018610430250843
  • BadanaAKChintalaMGavaraMMLipid rafts disruption induces apoptosis by attenuating expression of LRP6 and survivin in triple negative breast cancerBiomed Pharmacother20189735936829091885
  • WangRHeWLiZChangWXinYHuangTCaveolin-1 functions as a key regulator of 17β-estradiol-mediated autophagy and apoptosis in BT474 breast cancer cellsInt J Mol Med201434382282725017566
  • ShiYTanSHNgSCritical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagyAutophagy201511576978425945613
  • SalisOBedirAGultenSOkuyucuAKulcuCAlacamHCytotoxic effect of fluvastatin on MCF-7 cells possibly through a reduction of the mRNA expression levels of SGK1 and CaV1Cancer Biother Radiopharm201429936837525347557
  • SalisOBedirAOzdemirTOkuyucuAAlacamHThe relationship between anticancer effect of metformin and the transcriptional regulation of certain genes (CHOP, Cav-1, HO-1, SGK-1 and PAR-4) on MCF-7 cell lineEur Rev Med Pharmacol Sci201418111602160924943970
  • LeeEJYunUJKooKHDown-regulation of lipid raft-associated onco-proteins via cholesterol-dependent lipid raft internalization in docosahexaenoic acid-induced apoptosisBiochim Biophys Acta184120141190203
  • GoetzJGLajoiePWisemanSMNabiIRCaveolin-1 in tumor progression: the good, the bad and the uglyCancer Metastasis Rev200827471573518506396
  • BaileyKMLiuJCaveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinaseJ Biol Chem200828320137141372418332144
  • GaiXLuZTuKLiangZZhengXCaveolin-1 is up-regulated by Gli1 and contributes to GLI1-driven EMT in hepatocellular carcinomaPLoS One201491e8455124454730
  • LamouilleSXuJDerynckRMolecular mechanisms of epithelial-mesenchymal transitionNat Rev Mol Cell Biol201415317819624556840
  • CowinPWelchDRBreast cancer progression: controversies and consensus in the molecular mechanisms of metastasis and EMTJ Mammary Gland Biol Neoplasia2007122–39910218769505
  • Moreno-BuenoGPortilloFCanoATranscriptional regulation of cell polarity in EMT and cancerOncogene200827556958696919029937
  • HuangHMatrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advancesSensors201818103249
  • WangHZhuYZhaoMmiRNA-29c suppresses lung cancer cell adhesion to extracellular matrix and metastasis by targeting integrin β1 and matrix metalloproteinase2 (MMP2)PLoS One201388e7019223936390
  • PalSGangulyKKChatterjeeAExtracellular matrix protein fibronectin induces matrix metalloproteinases in human prostate adenocarcinoma cells PC-3Cell Commun Adhes201320510511424047237
  • YaoQKouLTuYZhuLMMP-responsive “smart” drug delivery and tumor targetingTrends Pharmacol Sci201839876678130032745
  • ZielinskaHAHollyJMPBahlAPerksCMCmPBahlAInhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanismCancer Lett201841918720229331414
  • TsaoSMHsuHYFucose-containing fraction of Ling-Zhi enhances lipid rafts-dependent ubiquitination of TGFβ receptor degradation and attenuates breast cancer tumorigenesisSci Rep201663656327830743
  • GallardoMCalafGMCurcumin and epithelial-mesenchymal transition in breast cancer cells transformed by low doses of radiation and estrogenInt J Oncol20164862534254227082017
  • Ponce-CusiRCalafGMAntitumor activity of pamidronate in breast cancer cells transformed by low doses of α-particles and estrogen in vitroInt J Oncol20154662663266925873070
  • ColeGMLimGPYangFPrevention of Alzheimer’s disease: omega-3 fatty acid and phenolic anti-oxidant interventionsNeurobiol Aging200526Suppl 113313616266772
  • ZhengWLiJWangXYuanYZhangJXiuZEffects of Antarctic krill docosahexaenoic acid on MCF-7 cell migration and invasion induced by the interaction of CD95 with caveolin-1Life Sci201819227027729129771
  • BraunACOlayioyeMARho regulation: DLC proteins in space and timeCell Signal20152781643165125889896
  • JoglekarMElbezantiWOWeitzmanMDLehmanHLvan GolenKLCaveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPaseJ Cell Biochem2015116692393325559359
  • YangBZhuWZhengZFluctuation of ROS regulates proliferation and mediates inhibition of migration by reducing the interaction between DLC1 and Cav-1 in breast cancer cellsIn Vitro Cell Dev Biol Anim201753435436228130753
  • KandpalRPRho GTPase activating proteins in cancer phenotypesCurr Protein Pept Sci20067435536516918449
  • DíazJMendozaPOrtizRRab5 is required in metastatic cancer cells for Caveolin-1-enhanced Rac1 activation, migration and invasionJ Cell Sci2014127Pt 112401240624659799
  • KozyulinaPYLoskutovYVKozyrevaVKPrometastatic NEDD9 regulates individual cell migration via caveolin-1-dependent trafficking of integrinsMol Cancer Res201513342343825319010
  • ChenYOlopadeOIMYC in breast tumor progressionExpert Rev Anticancer Ther20088101689169818925859
  • XiongNLiSTangKInvolvement of caveolin-1 in low shear stress-induced breast cancer cell motility and adhesion: roles of FAK/Src and ROCK/p-MLC pathwaysBiochim Biophys Acta Mol Cell Res1864201711222
  • ValastyanSWeinbergRATumor metastasis: molecular insights and evolving paradigmsCell2011147227529222000009
  • ChafferCLWeinbergRAA perspective on cancer cell metastasisScience201133160241559156421436443
  • GilmoreAPAnoikisCell Death Differ200512Suppl 21473147716247493
  • KimYNKooKHSungJYYunUJKimHAnoikis resistance: an essential prerequisite for tumor metastasisInt J Cell Biol201220124111
  • SimpsonCDAnyiweKSchimmerADAnoikis resistance and tumor metastasisCancer Lett2008272217718518579285
  • PaoliPGiannoniEChiarugiPAnoikis molecular pathways and its role in cancer progressionBiochim Biophys Acta183320131234813498
  • LiSChenYZhangYShear stress promotes anoikis resistance of cancer cells via caveolin-1-dependent extrinsic and intrinsic apoptotic pathwaysJ Cell Physiol201923443730374330171601
  • WangKZhuXChenYYinYMaTTubeimoside V sensitizes human triple negative breast cancer MDA-MB-231 cells to anoikis via regulating caveolin-1-related signaling pathwaysArch Biochem Biophys2018646101529580948
  • NimriLBarakHGraeveLSchwartzBRestoration of caveolin-1 expression suppresses growth, membrane-type-4 metalloproteinase expression and metastasis-associated activities in colon cancer cellsMol Carcinog2013521185987022674854
  • TruongAYipCPayeADynamics of internalization and recycling of the prometastatic membrane type 4 matrix metalloproteinase (MT4-MMP) in breast cancer cellsFEBS J2016283470472226663028
  • CelusWdi ConzaGOliveiraAILoss of caveolin-1 in metastasis-associated macrophages drives lung metastatic growth through increased angiogenesisCell Rep201721102842285429212030
  • LvWChenNLinYMacrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axisCancer Lett2016375224525526952810
  • AlevizosLKatakiADerventziABreast cancer nodal metastasis correlates with tumour and lymph node methylation profiles of caveolin-1 and CXCR4Clin Exp Metastasis201431551152024590865
  • KowalskaKNowakowskaMDomińskaKPiastowska-CiesielskaAWCoexpression of Cav-1, AT1-R and FoxM1 in prostate and breast cancer and normal cell lines and their influence on metastatic propertiesActa Biochim Pol201663349349927213551
  • MagbanuaMJMRugoHSHauraniehLGenomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancerNPJ Breast Cancer2018413130211312
  • KuczynskiEASargentDJGrotheyAKerbelRSDrug rechallenge and treatment beyond progression – implications for drug resistanceNat Rev Clin Oncol2013101057158723999218
  • MalliniPLennardTKirbyJMeesonAEpithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistanceCancer Treat Rev201440334134824090504
  • HehlgansSCordesNCaveolin-1: an essential modulator of cancer cell radio-and chemoresistanceAm J Cancer Res20111452153021984970
  • WangZLiuPChenQTargeting AMPK signaling pathway to overcome drug resistance for cancer therapyCurr Drug Targets201617885386425777274
  • WangZWangNLiWCaveolin-1 mediates chemoresistance in breast cancer stem cells via β-catenin/ABCG2 signaling pathwayCarcinogenesis201435102346235625085904
  • HerzogMStorchCHGutPKnockdown of caveolin-1 decreases activity of breast cancer resistance protein (BCRP/ABCG2) and increases chemotherapeutic sensitivityNaunyn Schmiedebergs Arch Pharmacol2011383111120936466
  • PengLChenXAntibody-drug conjugatesBioconjug Chem20152611216926577284
  • KimEGKimKMStrategies and advancement in antibody-drug conjugate optimization for targeted cancer therapeuticsBiomol Ther2015236493509
  • LorussoPMWeissDGuardinoEGirishSSliwkowskiMXTrastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancerClin Cancer Res201117206437644722003071
  • SekharSCKasaiTSatohAIdentification of caveolin-1 as a potential causative factor in the generation of trastuzumab resistance in breast cancer cellsJ Cancer20134539140123833684
  • ChungYCKuoJFWeiWCChangKJChaoWTCaveolin-1 dependent endocytosis enhances the chemosensitivity of HER-2 positive breast cancer cells to trastuzumab emtansine (T-DM1)PLoS One2015107e013307226172389
  • ChungYCChangCMWeiWCChangTWChangKJChaoWTMetformin-induced caveolin-1 expression promotes T-DM1 drug efficacy in breast cancer cellsSci Rep201881393029500444
  • von der HeydeSWagnerSCzernyAmRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancerPLoS One2015102e011781825710561
  • SungMTanXLuBCaveolae-mediated endocytosis as a novel mechanism of resistance to trastuzumab emtansine (T-DM1)Mol Cancer Ther201817124325329054985
  • ZhengYDaiYLiuWAstragaloside IV enhances taxol chemo-sensitivity of breast cancer via caveolin-1-targeting oxidant damageJ Cell Physiol201923444277429030146689
  • LiZYangSSYinPHActivated estrogen receptor-mitogen-activated protein kinases cross talk confer acquired resistance to lapatinibThoracic Cancer20156669570326557906
  • ZouMLiYXiaSKnockdown of caveolin-1 sensitizes human basal-like triple-negative breast cancer cells to radiationCell Physiol Biochem201744277879129169152
  • MalikBNieDCancer stem cells and resistance to chemo and radio therapyFront Biosci2012421422149
  • SzakácsGPatersonJKLudwigJABooth-GentheCGottesmanMMTargeting multidrug resistance in cancerNat Rev Drug Discov20065321923416518375
  • TrumppAWiestlerODMechanisms of disease: cancer stem cells – targeting the evil twinNat Clin Pract Oncol20085633734718431377
  • Maugeri-SaccàMVigneriPde MariaRCancer stem cells and chemosensitivityClin Cancer Res201117154942494721622723
  • DeanMABC transporters, drug resistance, and cancer stem cellsJ Mammary Gland Biol Neoplasia20091413919224345
  • DonnenbergVSMeyerEMDonnenbergADMeasurement of multiple drug resistance transporter activity in putative cancer stem/progenitor cellsMethods Mol Biol200956826127919582433
  • HirschHAIliopoulosDTsichlisPNStruhlKMetformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remissionCancer Res200969197507751119752085
  • Marie-EgyptienneDTLohseIHillRPCancer stem cells, the epithelial to mesenchymal transition (EMT) and radioresistance: potential role of hypoxiaCancer Lett20133411637223200673
  • Merlos-SuárezABarrigaFMJungPThe intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapseCell Stem Cell20118551152421419747
  • PeronaRLópez-AyllónBDde Castro CarpeñoJBelda-IniestaCA role for cancer stem cells in drug resistance and metastasis in non-small-cell lung cancerClin Transl Oncol201113528929321596655
  • SheridanCKishimotoHFuchsRKCD44+/CD24− breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasisBreast Cancer Res200685R5917062128
  • YuanGRegelILianFWNT6 is a novel target gene of caveo-lin-1 promoting chemoresistance to epirubicin in human gastric cancer cellsOncogene201332337538722370641
  • YongsanguanchaiNPongrakhananonVMutiranguraARojanasakulYChanvorachotePNitric oxide induces cancer stem cell-like phenotypes in human lung cancer cellsAm J Physiol Cell Physiol20153082C89C10025411331
  • EliyatkinNAktasSDinizGOzgurHHEkinZYKupeliogluAExpression of stromal caveolin-1 may be a predictor for aggressive behaviour of breast cancerPathol Oncol Res2018241596528236153
  • PucciMBravatàVForteGICaveolin-1, breast cancer and ionizing radiationCancer Genomics Proteomics201512314315225977173
  • WitkiewiczAKDasguptaANguyenKHStromal caveolin-1 levels predict early DCIS progression to invasive breast cancerCancer Biol Ther20098111071107919502809
  • SotgiaFMartinez-OutschoornUEHowellAPestellRGPavlidesSLisantiMPCaveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanismsAnnu Rev Pathol20127142346722077552
  • YeongJThikeAAIkedaMCaveolin-1 expression as a prognostic marker in triple negative breast cancers of Asian womenJ Clin Pathol201871216116728735300
  • LiXSunJHuSExpression of caveolin-1 in breast cancer stroma as a potential prognostic biomarker of survival and progression: a meta-analysisWien Klin Wochenschr201712915–1655856328364168
  • MaXLiuLNieWPrognostic role of caveolin in breast cancer: a meta-analysisBreast201322446246923639584
  • ElsheikhSEGreenARRakhaEACaveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotypeBr J Cancer200899232733418612310
  • QianNUenoTKawaguchi-SakitaNPrognostic significance of tumor/stromal caveolin-1 expression in breast cancer patientsCancer Sci201110281590159621585620
  • JensenDHTherkildsenMHDabelsteenEA reverse Warburg metabolism in oral squamous cell carcinoma is not dependent upon myofibroblastsJ Oral Pathol Med201544971472125420473
  • TasdemirNBossartEALiZComprehensive phenotypic characterization of human invasive lobular carcinoma cell lines in 2D and 3D culturesCancer Res201878216209622230228172
  • FardZTNafisiNThe relationship between 6 polymorphisms of caveolin-1 gene and the risk of breast cancerClin Breast Cancer2018185e893e89829525429
  • DebMSenguptaDKarSElucidation of caveolin 1 both as a tumor suppressor and metastasis promoter in light of epigenetic modulatorsTumour Biol20143512120311204725192721
  • ChanvorachotePChunhachaPCaveolin-1 regulates endothelial adhesion of lung cancer cells via reactive oxygen species-dependent mechanismPLoS One201382e5746623460862
  • WuJdiDZhaoCClinical significance of Gli-1 and caveolin-1 expression in the human small cell lung cancerAsian Pac J Cancer Prev201819240140629479989
  • ZhaoZHanFHYangSBHuaLXJhWZhanWHLoss of stromal caveolin-1 expression in colorectal cancer predicts poor survivalWorld J Gastroenterol20152141140114725632186
  • WangYSongYCheXCaveolin-1 enhances RANKL-induced gastric cancer cell migrationOncol Rep20184031287129630015970
  • LiangXChenWShiHPTBP3 contributes to the metastasis of gastric cancer by mediating CaV1 alternative splicingCell Death Dis20189556929752441
  • ZhangTWangTCaiPSclareol inhibits cell proliferation and sensitizes cells to the antiproliferative effect of bortezomib via upregulating the tumor suppressor caveolin-1 in cervical cancer cellsMol Med Rep20171563566357428440485
  • TakedaMSakaguchiTHiraideTRole of caveolin-1 in hepatocellular carcinoma arising from non-alcoholic fatty liver diseaseCancer Sci201810982401241129896915
  • DemirciNSDoganMErdemGUIs plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer?Saudi J Gastroenterol201723318318928611342
  • ZhouWHeLDaiYZhangYWangJLiuBMicroRNA-124 inhibits cell proliferation, invasion and migration by targeting CaV1 in bladder cancerExp Ther Med20181642811282030214503
  • Garcia-RivasGJerjes-SánchezCRodriguezDGarcia-PelaezJTrevinoVA systematic review of genetic mutations in pulmonary arterial hypertensionBMC Med Genet20171818228768485
  • KobayashiHKabataRKinoshitaHRare variants in RNF213, a susceptibility gene for moyamoya disease, are found in patients with pulmonary hypertension and aggravate hypoxia-induced pulmonary hypertension in micePulm Circ201883204589401877815
  • GirerdBLauEMontaniDHumbertMGenetics of pulmonary hypertension in the clinicCurr Opin Pulm Med201723538639128661905
  • MahdyMMEl-EkiabyNMHashishRMmiR-29a promotes lipid droplet and triglyceride formation in HCV infection by inducing expression of SREBP-1c and CaV1J Clin Transl Hepatol20164429329928097097
  • SomritMWatthammawutAChotwiwatthanakunCWeerach-atyanukulWThe key molecular events during Macrobrachium rosenbergii nodavirus (MrNV) infection and replication in Sf9 insect cellsVirus Res20162231927327530
  • HuZLiangMSoongTAlternative splicing of L-type Cav1.2 calcium channels: implications in cardiovascular diseasesGenes2017812344
  • ChenSWangXWangJGenomic variant in CaV1 increases susceptibility to coronary artery disease and myocardial infarctionAtherosclerosis201624614815626775120
  • TorellaDIaconettiCTaralloRmiRNA regulation of the hyperproliferative phenotype of vascular smooth muscle cells in diabetesDiabetes201867122554256830257973
  • XiangSSaremMShahSShastriVPLiposomal treatment of cancer cells modulates uptake pathway of polymeric nanoparticles by altering membrane stiffnessSmall20181414e170424529460335
  • HanBCopelandCAKawanoYCharacterization of a caveolin-1 mutation associated with both pulmonary arterial hypertension and congenital generalized lipodystrophyTraffic201617121297131227717241
  • BadanaAChintalaMVarikutiGLipid raft integrity is required for survival of triple negative breast cancer cellsJ Breast Cancer201619437238428053625